Trials / Unknown
UnknownNCT01594788
Neutrophil Gelatinase-associated Lipocalin as a New Biomarker to Detect Acute Kidney Injury in Postoperative Cardiac Surgery
NGAL as a Marker of Acute Kidney Injury After Cardiac Surgery. Observational Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 340 (planned)
- Sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Observational study aimed to test the ability of Neutrophil Gelatinase-associated Lipocalin (NGAL) concentration in blood and urine to predict and diagnose early acute renal failure (ARF) in patients after cardiac surgery with/without Cardiopulmonary bypass (CPB).
Conditions
Timeline
- Start date
- 2011-04-01
- Completion
- 2012-12-01
- First posted
- 2012-05-09
- Last updated
- 2012-05-09
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01594788. Inclusion in this directory is not an endorsement.